Critical Results Reporting in Portuguese Hospital Laboratories : State-of-the-Art
Copyright © 2020 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved..
INTRODUCTION: This survey aimed to assess the state-of-the-art of current practices on critical results reporting among Portuguese Clinical Pathology Laboratories. The results of the survey will set basis for future standardization and national guideline development.
MATERIALS AND METHODS: The survey was transmitted to 49 Clinical Pathology Laboratories among public hospitals inserted in the Portuguese National Health System. In 27 questions, laboratories were asked about their critical results procedures, critical results list, reporting and further education. Data were analyzed using Microsoft Excel v.2016 and MedCalc Statistical Software version 12.5.0.0 (Ostend, Belgium). Where applicable, the comparison of proportions was used to estimate the level of significance (P<0.05).
RESULTS: The response rate was 44/49 (90%), including 36 participants with a defined critical results reporting procedure. Among them, 31 laboratories defined a critical results list, mainly based on published literature (27/31). There was a statistically significant number of laboratories (P=0.019, 24/30) that report different critical results depending on the patient's age, but regardless of disease, ethnicity and location (P>0.05). The majority of laboratories (60%) report critical results via telephone within 15 minutes. Critical results are usually reported by clinical pathologists to physicians. Twenty-five laboratories periodically reevaluate their critical results list.
CONCLUSION: Despite the fact that most of the Portuguese hospitals have a critical results policy, this survey showed high variability among the hospitals concerning critical results reporting practices and critical results list. This survey points out that nationally established procedures and guidelines are urgent step for critical results standardization.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
EJIFCC - 31(2020), 2 vom: 10. Juni, Seite 145-156 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vuljanić, Dora [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 15.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM311286615 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311286615 | ||
| 003 | DE-627 | ||
| 005 | 20231225141929.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311286615 | ||
| 035 | |a (NLM)32549882 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vuljanić, Dora |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical Results Reporting in Portuguese Hospital Laboratories |b State-of-the-Art |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2020 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. | ||
| 520 | |a INTRODUCTION: This survey aimed to assess the state-of-the-art of current practices on critical results reporting among Portuguese Clinical Pathology Laboratories. The results of the survey will set basis for future standardization and national guideline development | ||
| 520 | |a MATERIALS AND METHODS: The survey was transmitted to 49 Clinical Pathology Laboratories among public hospitals inserted in the Portuguese National Health System. In 27 questions, laboratories were asked about their critical results procedures, critical results list, reporting and further education. Data were analyzed using Microsoft Excel v.2016 and MedCalc Statistical Software version 12.5.0.0 (Ostend, Belgium). Where applicable, the comparison of proportions was used to estimate the level of significance (P<0.05) | ||
| 520 | |a RESULTS: The response rate was 44/49 (90%), including 36 participants with a defined critical results reporting procedure. Among them, 31 laboratories defined a critical results list, mainly based on published literature (27/31). There was a statistically significant number of laboratories (P=0.019, 24/30) that report different critical results depending on the patient's age, but regardless of disease, ethnicity and location (P>0.05). The majority of laboratories (60%) report critical results via telephone within 15 minutes. Critical results are usually reported by clinical pathologists to physicians. Twenty-five laboratories periodically reevaluate their critical results list | ||
| 520 | |a CONCLUSION: Despite the fact that most of the Portuguese hospitals have a critical results policy, this survey showed high variability among the hospitals concerning critical results reporting practices and critical results list. This survey points out that nationally established procedures and guidelines are urgent step for critical results standardization | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a critical results | |
| 650 | 4 | |a laboratory management | |
| 650 | 4 | |a survey | |
| 700 | 1 | |a Pereira, Margarida |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Sérgio |e verfasserin |4 aut | |
| 700 | 1 | |a Nikler, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Biljak, Vanja Radišić |e verfasserin |4 aut | |
| 700 | 1 | |a Cachapuz, Isabel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EJIFCC |d 1999 |g 31(2020), 2 vom: 10. Juni, Seite 145-156 |w (DE-627)NLM264815653 |x 1650-3414 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2020 |g number:2 |g day:10 |g month:06 |g pages:145-156 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2020 |e 2 |b 10 |c 06 |h 145-156 | ||